Regeneron Pharmaceuticals (REGN)
Change in Working Capital
-$161.10M
Quarterly · Period ending: · USD

REGN Change in Working Capital
Latest reported-$161.10Mperiod ending
Latest reported-$161.10Mperiod ending
REGN Quarterly Change in Working Capital (-$1.40M → -$161.10M)
Quarterly change in working capital
High-resolution chart · PNG
REGN change in working capital history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Change in Working Capital (USD) |
|---|---|
| 3,603,000 | |
| 2,079,000 | |
| 1,985,000 | |
| -3,246,000 | |
| -2,527,000 | |
| -11,466,000 | |
| 5,500,000 | |
| -4,600,000 | |
| 1,600,000 | |
| -1,300,000 | |
| -1,800,000 | |
| 4,100,000 | |
| -7,700,000 | |
| -2,000,000 | |
| 1,000,000 | |
| -1,400,000 | |
| -1,700,000 | |
| -500,000 | |
| 2,600,000 | |
| -3,900,000 | |
| -3,400,000 | |
| -3,800,000 | |
| 3,400,000 | |
| -9,200,000 | |
| -2,400,000 | |
| -6,600,000 | |
| -8,500,000 | |
| -5,300,000 | |
| 12,300,000 | |
| -1,500,000 | |
| -400,000 | |
| 1,300,000 | |
| 900,000 | |
| 1,300,000 | |
| -200,000 | |
| 1,300,000 | |
| -200,000 | |
| 600,000 | |
| 1,300,000 | |
| -1,400,000 |